$4.10
0.01[0.24%]
At close: May 17
$4.0471
-0.0529[-1.29%]
After Hours: 9:21AM EDT
ADC Therapeutics
(NYSE:ADCT)ADC Therapeutics Stock (NYSE:ADCT), Earnings Estimates, EPS, and Revenue
ADC Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS
$-0.380
Quarterly Revenue
$18.1M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$68.6M
Analyze the earnings history of ADC Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADCT | ADC Therapeutics | -$0.37 | — | — | — | $19.28M | — | — | — | 08/06/2024 | Get Alert |
| ADCT | ADC Therapeutics | -$0.53 | -$0.56 | -$0.38 | 32.14% | $18.99M | $18.21M | $18.05M | -0.86% | 05/06/2024 | Get Alert |
| ADCT | ADC Therapeutics | -$0.08 | -$0.50 | -$0.97 | -94.00% | $69.80M | $15.33M | $16.79M | 9.52% | 03/13/2024 | Get Alert |
| ADCT | ADC Therapeutics | $0.13 | -$0.63 | -$0.41 | 34.92% | $76.32M | $15.99M | $14.49M | -9.36% | 11/07/2023 | Get Alert |
| ADCT | ADC Therapeutics | -$0.73 | -$0.44 | -$0.37 | 15.91% | $17.29M | $34.77M | $19.28M | -44.54% | 08/08/2023 | Get Alert |
| ADCT | ADC Therapeutics | -$0.36 | -$0.67 | -$0.53 | 20.90% | $46.50M | $20.09M | $18.99M | -5.47% | 05/09/2023 | Get Alert |
| ADCT | ADC Therapeutics | -$0.39 | -$0.29 | -$0.10 | 65.52% | $17.01M | $65.49M | $69.80M | 6.58% | 02/28/2023 | Get Alert |
| ADCT | ADC Therapeutics | -$0.59 | -$0.35 | $0.13 | 137.14% | $13.15M | $47.01M | $76.32M | 62.35% | 11/08/2022 | Get Alert |
| ADCT | ADC Therapeutics | -$0.70 | -$0.91 | -$0.73 | 19.78% | $3.76M | $20.51M | $17.29M | -15.69% | 08/09/2022 | Get Alert |
| ADCT | ADC Therapeutics | -$0.74 | -$0.70 | -$0.36 | 48.57% | $0.00 | $28.94M | $46.50M | 60.67% | 05/09/2022 | Get Alert |
| ADCT | ADC Therapeutics | -$0.82 | -$0.86 | -$0.39 | 54.65% | $0.00 | $16.46M | $17.01M | 3.34% | 03/03/2022 | Get Alert |
| ADCT | ADC Therapeutics | -$0.58 | -$0.92 | -$0.59 | 35.87% | $0.00 | $7.39M | $13.15M | 77.90% | 11/02/2021 | Get Alert |
| ADCT | ADC Therapeutics | -$0.51 | -$0.82 | -$0.70 | 14.63% | $0.00 | $2.37M | $3.76M | 58.65% | 08/03/2021 | Get Alert |
| ADCT | ADC Therapeutics | — | -$0.90 | -$0.74 | 17.78% | — | $90.00K | $0.00 | -100.00% | 05/06/2021 | Get Alert |
| ADCT | ADC Therapeutics | — | -$0.38 | -$0.82 | -115.79% | — | $860.00K | $0.00 | -100.00% | 03/18/2021 | Get Alert |
| ADCT | ADC Therapeutics | — | -$0.81 | -$0.58 | 28.40% | — | $40.00K | $0.00 | -100.00% | 11/12/2020 | Get Alert |
| ADCT | ADC Therapeutics | — | -$0.67 | -$0.51 | 23.88% | — | $290.00K | $0.00 | -100.00% | 08/18/2020 | Get Alert |
FAQ
When is ADC Therapeutics (NYSE:ADCT) reporting earnings?
ADC Therapeutics (ADCT) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 6, 2024 for Q1.
What were the latest earnings per share (EPS) for ADC Therapeutics (NYSE:ADCT)?
The Actual EPS was $-0.38, which beat the estimate of $-0.56.
What were ADC Therapeutics’s (NYSE:ADCT) revenues?
The Actual Revenue was $18.1M, which missed the estimate of $18.2M.
Browse earnings estimates, EPS, and revenue on all stocks.